Ir para o conteúdo principal

Stryker (NYSE: SYK) — Perfil da empresa, notícias e dados financeiros

Logo de Stryker
SYK Stryker
A medical facility with equipments.
Perfil da empresa

Stryker

Stryker is a global medical technology company headquartered in Kalamazoo, Michigan. The company develops, manufactures, and markets medical equipment, surgical implants, neurotechnology products, and orthopaedic devices. Its product portfolio encompasses joint replacement implants, robotic-assisted surgical platforms, surgical instruments, patient handling equipment, neurosurgical tools, and emergency medical tools. Stryker supplies hospitals, ambulatory surgery centers, and healthcare providers globally across more than 70 countries. The business operates through two principal reporting segments: MedSurg and Neurotechnology, and Orthopaedics and Spine, focusing on delivering solutions that improve surgical precision, patient safety, and clinical efficiency.

Resumo

Public USParticipação acionária
1946Ano de fundação
~56,000Funcionários
Portage, United StatesSede
Carregando mapa...
Presença global

Operações

Produtos e/ou serviços de Stryker

  • Orthopaedic Implants: Manufacturing and global supply of hip, knee, and trauma implants, alongside joint replacement systems designed to restore mobility and treat degenerative joint diseases and complex traumatic bone fractures in adult and pediatric patients.
  • Robotic-Assisted Surgical Systems: Development and deployment of computer-assisted surgical robotic platforms, navigation systems, and digital software suites that assist surgeons in planning and executing precise joint arthroplasty, spinal procedures, and orthopaedic reconstructive operations.
  • Surgical Equipment and Endoscopy: Production of powered surgical handpieces, surgical navigation tools, endoscopic visualization equipment, surgical room waste management systems, and clinical infrastructure products utilized across operating rooms and surgical centers globally.
  • Neurotechnology and Spine Systems: Design and global supply of neurovascular products, specialized neurosurgical equipment, spinal hardware implants, and interventional devices used for treating ischemic stroke, cerebral aneurysm repair, spinal deformities, and complex back conditions.
  • Medical Beds and Patient Handling: Manufacture and distribution of hospital care beds, specialized stretchers, patient transfer equipment, emergency medical response gear, automated external defibrillators, and clinical temperature management devices for emergency medical services and acute healthcare.
  • Reprocessing and Sustainability Solutions: Provision of medical device remanufacturing and reprocessing services, alongside sustainable healthcare supplies that allow hospitals and outpatient centers to reduce medical waste, lower operating expenditures, and optimize supply chain usage.

equipe executiva do Stryker

  • Kevin A. LoboChairman & CEO
  • Spencer S. StilesPresident & COO
  • Preston W. WellsVP & CFO
  • Viju S. MenonGroup President of Global Quality & Operations
  • J. Andrew PierceGroup President of MedSurg & Neurotechnology
  • Emily BaculikVP, Chief Accounting Officer & Corporate Controller
  • Robert C. CohenCTO and VP of Global R&D - Joint Replacement
  • Debra S. KingVP and Chief Digital & Information Officer
  • Nick MeadVice President of Investor Relations
  • Robert S. FletcherVP & Chief Legal Officer

Histórico de dividendos

Dividendos por ação pagos pela Stryker , por ano fiscal.

Dividendos por ação da Stryker por ano fiscal
Ano fiscalIntermediárioFinalEspecialTotal
FY2026(até o momento)———$2.6400
FY2025———$3.4000
FY2024———$3.2400
FY2023———$3.0500
FY2022———$2.8350

Principais indicadores financeiros

Resultados divulgados pela Stryker , em USD.

Cap. de mercado
121,1 bi
Receita (TTM)
26,3 bi
P/L
33.9
LPA (diluído, TTM)
9.4
Dividend yield
1.1%
Margem de lucro
13.8%
Receita e lucro anuais da Stryker
Fim do ano fiscalReceitaResultado operacionalLucro líquido
25,1 bi4,9 bi3,2 bi
22,6 bi3,7 bi3 bi
20,5 bi4,3 bi3,2 bi
18,4 bi3,7 bi2,4 bi